Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridinium ion (MPP+) decrease dopamine and increase acetylcholine in the mouse neostriatum
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 24 (6) , 585-586
- https://doi.org/10.1016/0028-3908(85)90069-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Acetylcholine measurement by high-performance liquid chromatography using an enzyme-loaded postcolumn reactorAnalytical Biochemistry, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigraNeuroscience Letters, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Epinephrine: A Potential Neurotransmitter in RetinaJournal of Neurochemistry, 1983